Keywords: genta, enrolls, first, patients, ph, iii, genasense

Genta enrolls first patients in Ph III Genasense trial

Article | 03 September 2007

Print This

US drugmaker Genta says that the first patients have been enrolled in the confirmatory Phase III trial of Genasense (oblimersen ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in